Is familial hyperaldosteronism underdiagnosed in hypertensive children?

Hypertension

Volumn 57, Issue 6, 2011, Pages 1054-1055

  Mulatero, Paolo ^a,b   Williams, Tracy Ann ^a   Monticone, Silvia ^a   Veglio, Franco ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE SYNTHASE; CORTICOTROPIN; DEXAMETHASONE; MINERALOCORTICOID RECEPTOR; POTASSIUM CHANNEL KCNJ5; RENIN; STEROID 11BETA MONOOXYGENASE; UNCLASSIFIED DRUG; VOLTAGE GATED POTASSIUM CHANNEL; ALDOSTERONE; POTASSIUM;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ADOLESCENT; ADRENALECTOMY; AUTOSOMAL DOMINANT DISORDER; CHILD; CHILE; CHROMOSOME 7P; CORTICOTROPIN RELEASE; DISEASE SEVERITY; EDITORIAL; FAMILIAL DISEASE; FAMILIAL HYPERALDOSTERONISM; FAMILIAL HYPERALDOSTERONISM TYPE I; FAMILIAL HYPERALDOSTERONISM TYPE II; FAMILIAL HYPERALDOSTERONISM TYPE III; GENE MUTATION; GENE SEQUENCE; GENETIC DISORDER; GENETIC LINKAGE; HUMAN; HYPERALDOSTERONISM; HYPERTENSION; INCIDENCE; ONSET AGE; PEDIATRIC HYPERTENSION; PLASMA RENIN ACTIVITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOMATIC MUTATION; BLOOD; BLOOD PRESSURE; COMORBIDITY; FAMILY HEALTH; GENE FUSION; GENETICS; NOTE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PREVALENCE;

ALDOSTERONE; ALDOSTERONE SYNTHASE; BLOOD PRESSURE; CHILD; CHILE; COMORBIDITY; FAMILY HEALTH; GENE FUSION; HUMANS; HYPERALDOSTERONISM; HYPERTENSION; POTASSIUM; PREVALENCE; RENIN; STEROID 11-BETA-HYDROXYLASE;

EID: 79956351000     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.111.172916     Document Type: Editorial

References (12)

1. Mulatero P, Monticone S, Veglio F. Diagnosis and treatment of primary aldosteronism. Rev Endocr Metab Disord. In press.
2. Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M, Young WF Jr, Montori VM; Endocrine Society. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2008;93: 3266-3281.
3. Lifton RP, Dluhy RG, Powers M, Rich GM, Gutkin M, Fallo F, Gill JR Jr, Feld L, Ganguly A, Laidlaw JC. Hereditary hypertension caused by chimaeric gene duplications and ectopic expression of aldosterone synthase. Nat Genet. 1992;2:66-74.
4. Mulatero P, Morra di Cella S, Williams TA, Milan A, Mengozzi G, Chiandussi L, Gomez-Sanchez CE, Veglio F. Glucocorticoid remediable aldosteronism: low morbidity and mortality in a four-generation italian pedigree. J Clin Endocrinol Metab. 2002;87:3187-3191. (Pubitemid 34816363)
5. Sukor N, Mulatero P, Gordon RD, So A, Duffy D, Bertello C, Kelemen L, Jeske Y, Veglio F, Stowasser M. Further evidence for linkage of familial hyperaldosteronism type II at chromosome 7p22 in Italian as well as Australian and South American families. J Hypertens. 2008;26: 1577-1582.
6. Newton-Cheh C, Guo CY, Gona P, Larson MG, Benjamin EJ, Wang TJ, Kathiresan S, O'Donnell CJ, Musone SL, Camargo AL, Drake JA, Levy D, Hirschhorn JN, Vasan RS. Clinical and genetic correlates of aldosterone-to-renin ratio and relations to blood pressure in a community sample. Hypertension. 2007;49:846-856. (Pubitemid 351664212)
7. Choi M, Scholl UI, Yue P, Björklund P, Zhao B, Nelson-Williams C, Ji W, Cho Y, Patel A, Men CJ, Lolis E, Wisgerhof MV, Geller DS, Mane S, Hellman P, Westin G, Åkerström G, Wang W, Carling T, Lifton RP. Kα channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science. 2011;331:768-772.
8. Brady TM, Feld LG. Pediatric approach to hypertension. Semin Nephrol. 2009;29:379-388.
9. Aglony M, Martínez-Aguayo A, Carvajal CA, Campino C, García H, Bancalari R, Bolte L, Avalos C, Loureiro C, Trejo P, Brinkmann K, Giadrosich V, Mericq V, Rocha A, Avila A, Perez V, Inostroza A, Fardella CE. Frequency of familial hyperaldosteronism type 1 in a hypertensive pediatric population: clinical and biochemical presentation. Hypertension. 2011;57:1117-1121.
10. Martinez-Aguayo A, Aglony M, Campino C, Garcia H, Bancalari R, Bolte L, Avalos C, Loureiro C, Carvajal CA, Avila A, Perez V, Inostroza A, Fardella CE. Aldosterone, plasma renin activity, and aldosterone/renin ratio in a normotensive healthy pediatric population. Hypertension. 2010; 56:391-396.
11. Gates LJ, Benjamin N, Haites NE, MacConnachie AA, McLay JS. Is random screening of value in detecting glucocorticoid-remediable aldosteronism within a hypertensive population? J Hum Hypertens. 15: 173-176.
12. Fardella CE, Mosso L, Gómez-Sánchez C, Cortés P, Soto J, Gómez L, Pinto M, Huete A, Oestreicher E, Foradori A, Montero J. Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology. J Clin Endocrinol Metab. 2000;85:1863-1867. (Pubitemid 32269290)